197015-32-0

Basic information

• Product Name: Methanesulfonic acid, trifluoro-, 2-formyl-5-methoxyphenyl ester
• CAS NO: 197015-32-0
• Molecular Formula: C9H7F3O5S
• Molecular Weight: 284.213
• Mol File: 197015-32-0.mol

Chemical Properties

• CAS DataBase Reference: Methanesulfonic acid, trifluoro-, 2-formyl-5-methoxyphenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Methanesulfonic acid, trifluoro-, 2-formyl-5-methoxyphenyl ester(197015-32-0)
• EPA Substance Registry System: Methanesulfonic acid, trifluoro-, 2-formyl-5-methoxyphenyl ester(197015-32-0)

Safety Data

• Hazardous Substances Data: 197015-32-0(Hazardous Substances Data)

Upstream product

• 673-22-3 2-Hydroxy-4-methoxybenzaldehyde 
• 358-23-6 trifluoromethylsulfonic anhydride 
• 37595-74-7 N,N-phenylbistrifluoromethane-sulfonimide 

Downstream Products

• 177937-97-2 4-methoxy-2-(2-trimethylsilylethynyl)benzaldehyde 
• 1196473-37-6 6-hydroxyl-1,3-dihydro-1-hydroxy-2,1-benzoxaborole 
• 947163-26-0 6-methoxybenzo[c][1,2]oxaborol-1(3H)-ol 
• 1196473-62-7 2-(1-hydroxy-1,3-dihydro-benzo[c][1,2]oxaborol-6-yloxy)-pyrimidine-5-carboxylic acid 
• 65908-33-0 6-methoxy-2,3-diphenyl-1H-inden-1-one 
• 92753-20-3 5-methoxy-3-phenylisobenzofuran-1(3H)-one 
• 1392144-08-9 C₂₉H₂₈N₄O₅S₂ 
• 1196474-59-5 4-methoxy-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde 
• 197015-33-1 1-Cyclopropylidenemethyl-4-methoxy-2-vinyl-benzene 
• 215671-88-8 2-(2,2-Dibromo-vinyl)-5-methoxy-benzoic acid methyl ester 
• 77620-05-4 methyl 5-methoxyl-2-formylbenzoate 
• 14963-94-1 7-methoxy-3-phenyl-1H-isochromen-1-one 
• 682356-54-3 C₃₂H₃₁NO₅ 
• 682356-50-9 C₂₆H₂₀O₅ 

Relevant articles and documents

ORGANIC ELECTROLUMINESCENT DEVICE

Disclosed is an organic electroluminescent device that employs a compound represented by Formula A-1 or A-2: and a compound represented by Formula B: The organic electroluminescent device has excellent luminescent properties such as high color purity and long lifetime.

Preparation method of phenylboronic acid half ester

The invention discloses a preparation method of phenylboronic acid half ester. The structural formula of the phenylboronic acid half ester prepared by the method is shown in the specification. The method is mild in reaction condition, the raw materials ar

Construction of spirofused tricyclic frameworks by NHC-catalyzed intramolecular stetter reaction of a benzaldehyde tether with a cyclic exsnone

Various benzaldehyde tethers with a cyclic enone were prepared from commercially available 2-hydroxybenzaldehydes via a three-step sequence involving triflate formation, Sonogashira cross-coupling, and regioselective hydrogenation. These substrates were t

Pd(II)-catalyzed one-pot, three-step route for the synthesis of unsymmetrical acridines

Unsymmetric acridines are synthesized via a one-pot amination/cyclization/ aromatization reaction for the first time. With Pd(OAc)2-X-Phos as the catalyst, a series of unsymmetric acridines are obtained in moderate to excellent yields (up to 99

Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors

A new class of benzoxaborole β-lactamase inhibitors were designed and synthesized. 6-Aryloxy benzoxaborole 22 inhibited AmpC P99 and CMY-2 with K i values in the low nanomolar range. Compound 22 restored antibacterial activity of ceftazidime against Enterobacter cloacae P99 expressing AmpC, a class C β-lactamase enzyme. The SAR around the arylbenzoxaboroles, which included the influence of linker and substitutions was also established.

NAPHTHYLACETIC ACIDS

The invention is concerned with the compounds of formula (I) and pharmaceutically acceptable salts and esters thereof, wherein X, Q, and R1-R6 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists or partial agonists at the CRTH2 receptor and may be useful in treating diseases and disorders associated with that receptor such as asthma.

BORON-CONTAINING SMALL MOLECULES

This invention relates to, among other items, 6-substituted benzoxaborole compounds and their use for treating bacterial infections.

Electronic control of product distribution in the [5+5]-coupling of ortho-alkynylbenzaldehyde derivatives and γ,δ-unsaturated carbene complexes

The coupling of highly oxygenated ortho-alkynylbenzaldehyde derivatives with γ,δ-carbene complexes was evaluated systematically. In all of the electron-rich systems investigated the exclusive product of the reaction is the dihydrophenanthrene derivative.

Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease

We disclose here a series of P4-benzoxaborole-substituted macrocyclic HCV protease inhibitors. These inhibitors are potent against HCV NS3 protease, their anti-HCV replicon potencies are largely impacted by substitutions on benzoxaborole ring system and P2 groups. P2 2-thiazole-isoquinoline provides best replicon potency. The in vitro SAR studies and in vivo PK evaluations of selected compounds are described herein.